Dietary protein defends lean mass and maintains the metabolic benefits of glucagon receptor agonism in mice

Glucagon-mediated energy expenditure and weight loss may be mechanistically coupled to hypoaminocidemia and lean mass loss. However, our data suggest that glucagon can treat MAFLD at doses which allow full defence of lean mass given sufficient dietary protein intake. Therefore, proportionate glucagon therapy may be safe and effective in targeting hepatocytes and improving in glycaemia and liver fat.

Authors

Institutions

Publication Details

Journal
Molecular Metabolism
Published
2024-09-03
DOI
https://doi.org/10.1016/j.molmet.2024.102024
Citations
3
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
1.07

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Dietary protein defends lean mass and maintains the metabolic benefits of glucagon receptor agonism in mice

Dirk Dormann, David Carling, Tatiana Lopes, Tricia Tan et al.
3 citations
Molecular Metabolism
Diabetes Treatment and Management
1.07
article

Dietary protein defends lean mass and maintains the metabolic benefits of glucagon receptor agonism in mice

Dirk Dormann, David Carling, Tatiana Lopes, Tricia Tan, Kevin G. Murphy, David C. D. Hope, Bryn M. Owen, Alessandro Sardini, José M. Ramos Pittol, Jed Valentiner Shrewsbury, Gavin A. Bewick, Iona Davies, James Minnion, Zijing Zhou, Stephen R. Bloom, Anna Curtis
article en
3 citations

Abstract

Glucagon-mediated energy expenditure and weight loss may be mechanistically coupled to hypoaminocidemia and lean mass loss. However, our data suggest that glucagon can treat MAFLD at doses which allow full defence of lean mass given sufficient dietary protein intake. Therefore, proportionate glucagon therapy may be safe and effective in targeting hepatocytes and improving in glycaemia and liver fat.

Molecular MetabolismVol. 89
King's College London (GB), Universität Innsbruck (AT), NIHR Imperial Biomedical Research Centre (GB), MRC London Institute of Medical Sciences (GB), Imperial College London (GB)
Wellcome Trust, District of Columbia Department of Health, National Institute for Health and Care Research, Royal Society, Diabetes UK, Tiroler Wissenschaftsförderung, Standortagentur Tirol, Medical Research Council, Biotechnology and Biological Sciences Research Council
Zero hunger
Openalex Percentile: Top 20%
Diabetes Treatment and Management
1.07
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.